nomifensine has been researched along with Hyperphagia in 3 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Hyperphagia: Ingestion of a greater than optimal quantity of food.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pope, HG | 2 |
| Hudson, JI | 2 |
| Herridge, PL | 1 |
| Fontaine, R | 1 |
| Yurgelun-Todd, D | 1 |
| Nassr, DG | 1 |
1 review available for nomifensine and Hyperphagia
| Article | Year |
|---|---|
Antidepressant drug therapy for bulimia: current status.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method | 1986 |
1 trial available for nomifensine and Hyperphagia
| Article | Year |
|---|---|
Antidepressant drug therapy for bulimia: current status.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method | 1986 |
2 other studies available for nomifensine and Hyperphagia
| Article | Year |
|---|---|
Treatment of bulimia with nomifensine.
Topics: Adult; Feeding and Eating Disorders; Female; Fever; Humans; Hyperphagia; Male; Nomifensine | 1986 |
Successful treatment of bulimia with nomifensine.
Topics: Adolescent; Adult; Feeding and Eating Disorders; Female; Follow-Up Studies; Humans; Hyperphagia; Nom | 1986 |